H Graeff Selected Research

H Graeff Research Topics

11	Neoplasms (Cancer) 11/2001 - 01/2000
11	Breast Neoplasms (Breast Cancer) 06/2001 - 01/2000
6	Neoplasm Metastasis (Metastasis) 05/2001 - 01/2000
2	Carcinoma (Carcinomatosis) 11/2001 - 12/2000
2	Ovarian Neoplasms (Ovarian Cancer) 05/2001 - 01/2001
1	Ascites 11/2001
1	Neoplasm Micrometastasis 07/2000
1	Noninfiltrating Intraductal Carcinoma (DCIS) 06/2000
1	Residual Neoplasm 04/2000

7	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 06/2001 - 01/2000
5	Serine Proteases (Serine Protease)IBA 05/2001 - 01/2000
4	Plasminogen Activator Inhibitor 1IBA 06/2001 - 01/2000
3	Proteins (Proteins, Gene)FDA Link 06/2001 - 01/2000
3	Plasminogen InactivatorsIBA 06/2001 - 01/2000
3	Urokinase Plasminogen Activator ReceptorsIBA 05/2001 - 02/2000
3	AntigensIBA 02/2000 - 01/2000
2	Peptide Hydrolases (Proteases)FDA Link 01/2001 - 06/2000
2	RNA (Ribonucleic Acid)IBA 06/2000 - 06/2000
2	Messenger RNA (mRNA)IBA 06/2000 - 01/2000
2	Biological FactorsIBA 01/2000 - 01/2000
1	PlatinumIBA 11/2001
1	taxaneIBA 11/2001
1	LipidsIBA 05/2001
1	Polysaccharides (Glycans)IBA 05/2001
1	Plasminogen Activators (Plasminogen Activator)IBA 01/2001
1	Biological ProductsIBA 01/2001
1	Indicators and Reagents (Reagents)IBA 12/2000
1	Complementary DNA (cDNA)IBA 12/2000
1	Fluorine-18IBA 10/2000
1	Monoclonal AntibodiesIBA 07/2000
1	Human Serum Albumin FDA LinkGeneric 07/2000
1	rac1 GTP-Binding ProteinIBA 06/2000
1	Protein Isoforms (Isoforms)IBA 06/2000
1	ParaffinIBA 06/2000
1	Formaldehyde (Formol)FDA Link 06/2000
1	PlasminogenIBA 02/2000
1	Keratins (Keratin)IBA 01/2000
1	Cathepsin DIBA 01/2000
1	Progesterone Receptors (Progesterone Receptor)IBA 01/2000
1	Estrogens (Estrogen)FDA Link 01/2000
1	Detergents (Detergent)IBA 01/2000
1	CathepsinsIBA 01/2000
1	Cathepsin BIBA 01/2000
1	Biomarkers (Surrogate Marker)IBA 01/2000
1	AntibodiesIBA 01/2000

5	Therapeutics 11/2001 - 01/2000
4	Drug Therapy (Chemotherapy) 11/2001 - 01/2000
2	Neoadjuvant Therapy 11/2001 - 04/2000
2	Combination Drug Therapy (Combination Chemotherapy) 11/2001 - 06/2001
2	Adjuvant Chemotherapy 06/2001 - 01/2000
1	Blood Transfusion (Blood Transfusions) 11/2001
1	Biological Therapy 01/2000